Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...